Clasificación en acciones
#32150
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Precio por acción
$1.49
Última sincronización: 2026-08-17
Capitalización bursátil
$10.94M
Comercio Ainos, Inc. (AIMD)
Precio AIMD con Capital del mercado a B
Capitalización de mercado de Ainos, Inc.(AIMD)
Capitalización bursátil: $10.94M
A fecha de August 2026, Ainos, Inc. tiene una capitalización de mercado de $10.94M. Esto convierte a Ainos, Inc. en la 32150th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Ainos, Inc. desde 2021 hasta 2026
AIMD en comparación con los más populares 5 títulos stocks
| Precio por AIMD |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.460T
|
+49,926,451.49%
|
|
|
|
|
$4.489T
|
+41,050,947.33%
|
|
|
|
|
$4.141T
|
+37,863,476.22%
|
|
|
|
|
$3.569T
|
+32,629,940.70%
|
|
|
|
|
$2.798T
|
+25,584,584.04%
|
